Annual Retained Earnings
-$1.40 B
-$141.43 M-11.26%
31 December 2023
Summary:
Celldex Therapeutics annual retained earnings is currently -$1.40 billion, with the most recent change of -$141.43 million (-11.26%) on 31 December 2023. During the last 3 years, it has fallen by -$324.26 million (-30.22%). CLDX annual retained earnings is now -48084.86% below its all-time high of -$2.90 million, reached on 30 April 1986.CLDX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.51 B
-$42.12 M-2.87%
01 September 2024
Summary:
Celldex Therapeutics quarterly retained earnings is currently -$1.51 billion, with the most recent change of -$42.12 million (-2.87%) on 01 September 2024. Over the past year, it has dropped by -$154.08 million (-11.38%). CLDX quarterly retained earnings is now -51904.55% below its all-time high of -$2.90 million, reached on 30 April 1986.CLDX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.3% | -11.4% |
| 3 y3 years | -30.2% | -34.2% |
| 5 y5 years | -45.2% | -50.4% |
CLDX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -30.2% | at low | -34.2% | at low |
| 5 y | 5 years | -45.2% | at low | -50.4% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Celldex Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.51 B(+2.9%) |
| June 2024 | - | -$1.47 B(+2.5%) |
| Mar 2024 | - | -$1.43 B(+2.3%) |
| Dec 2023 | -$1.40 B(+11.3%) | -$1.40 B(+3.2%) |
| Sept 2023 | - | -$1.35 B(+2.9%) |
| June 2023 | - | -$1.32 B(+2.4%) |
| Mar 2023 | - | -$1.29 B(+2.3%) |
| Dec 2022 | -$1.26 B(+9.8%) | -$1.26 B(+2.2%) |
| Sept 2022 | - | -$1.23 B(+2.2%) |
| June 2022 | - | -$1.20 B(+3.1%) |
| Mar 2022 | - | -$1.17 B(+2.0%) |
| Dec 2021 | -$1.14 B(+6.6%) | -$1.14 B(+1.8%) |
| Sept 2021 | - | -$1.12 B(+1.9%) |
| June 2021 | - | -$1.10 B(+1.2%) |
| Mar 2021 | - | -$1.09 B(+1.5%) |
| Dec 2020 | -$1.07 B(+5.9%) | -$1.07 B(+2.1%) |
| Sept 2020 | - | -$1.05 B(+1.4%) |
| June 2020 | - | -$1.04 B(+1.1%) |
| Mar 2020 | - | -$1.03 B(+1.2%) |
| Dec 2019 | -$1.01 B(+5.3%) | -$1.01 B(+1.0%) |
| Sept 2019 | - | -$1.00 B(+1.2%) |
| June 2019 | - | -$991.46 M(+1.2%) |
| Mar 2019 | - | -$979.68 M(+1.8%) |
| Dec 2018 | -$962.44 M(+18.5%) | -$962.44 M(+1.0%) |
| Sept 2018 | - | -$953.04 M(+0.8%) |
| June 2018 | - | -$945.79 M(+1.8%) |
| Mar 2018 | - | -$929.39 M(+14.4%) |
| Dec 2017 | -$812.52 M(+12.9%) | -$812.52 M(+0.5%) |
| Sept 2017 | - | -$808.68 M(+3.4%) |
| June 2017 | - | -$782.31 M(+3.8%) |
| Mar 2017 | - | -$753.75 M(+4.8%) |
| Dec 2016 | -$719.49 M(+21.7%) | -$719.49 M(+4.7%) |
| Sept 2016 | - | -$687.18 M(+4.5%) |
| June 2016 | - | -$657.58 M(+5.1%) |
| Mar 2016 | - | -$625.63 M(+5.9%) |
| Dec 2015 | -$590.96 M(+27.4%) | -$590.96 M(+5.9%) |
| Sept 2015 | - | -$558.27 M(+6.1%) |
| June 2015 | - | -$526.29 M(+6.6%) |
| Mar 2015 | - | -$493.93 M(+6.5%) |
| Dec 2014 | -$463.76 M(+34.2%) | -$463.76 M(+7.4%) |
| Sept 2014 | - | -$431.94 M(+7.0%) |
| June 2014 | - | -$403.86 M(+7.5%) |
| Mar 2014 | - | -$375.58 M(+8.7%) |
| Dec 2013 | -$345.68 M(+30.9%) | -$345.68 M(+6.8%) |
| Sept 2013 | - | -$323.62 M(+7.7%) |
| June 2013 | - | -$300.48 M(+6.8%) |
| Mar 2013 | - | -$281.46 M(+6.6%) |
| Dec 2012 | -$264.13 M(+28.8%) | -$264.13 M(+6.8%) |
| Sept 2012 | - | -$247.32 M(+6.5%) |
| June 2012 | - | -$232.29 M(+6.3%) |
| Mar 2012 | - | -$218.52 M(+6.6%) |
| Dec 2011 | -$205.01 M(+28.0%) | -$205.01 M(+6.6%) |
| Sept 2011 | - | -$192.27 M(+6.5%) |
| June 2011 | - | -$180.50 M(+6.0%) |
| Mar 2011 | - | -$170.27 M(+6.3%) |
| Dec 2010 | -$160.21 M(+1.6%) | -$160.21 M(-12.4%) |
| Sept 2010 | - | -$182.87 M(+5.2%) |
| June 2010 | - | -$173.78 M(+5.8%) |
| Mar 2010 | - | -$164.26 M(+4.2%) |
| Dec 2009 | -$157.67 M(+30.1%) | -$157.67 M(+8.9%) |
| Sept 2009 | - | -$144.73 M(+5.2%) |
| June 2009 | - | -$137.56 M(+6.8%) |
| Mar 2009 | - | -$128.85 M(+6.4%) |
| Dec 2008 | -$121.15 M(+64.5%) | -$121.15 M(+6.6%) |
| Sept 2008 | - | -$113.70 M(+7.2%) |
| June 2008 | - | -$106.04 M(+10.7%) |
| Mar 2008 | - | -$95.78 M(+30.0%) |
| Dec 2007 | -$73.65 M(-71.3%) | -$73.65 M(-73.0%) |
| Sept 2007 | - | -$272.63 M(+2.0%) |
| June 2007 | - | -$267.38 M(+2.1%) |
| Mar 2007 | - | -$261.87 M(+2.2%) |
| Dec 2006 | -$256.25 M | -$256.25 M(+2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | -$250.03 M(+2.3%) |
| June 2006 | - | -$244.51 M(+2.4%) |
| Mar 2006 | - | -$238.84 M(+1.3%) |
| Dec 2005 | -$235.87 M(+8.3%) | -$235.87 M(+1.7%) |
| Sept 2005 | - | -$231.89 M(+2.0%) |
| June 2005 | - | -$227.38 M(+2.1%) |
| Mar 2005 | - | -$222.64 M(+2.2%) |
| Dec 2004 | -$217.78 M(+6.5%) | -$217.78 M(+1.7%) |
| Sept 2004 | - | -$214.08 M(+1.8%) |
| June 2004 | - | -$210.38 M(+1.9%) |
| Mar 2004 | - | -$206.48 M(+0.9%) |
| Dec 2003 | -$204.57 M(+6.6%) | -$204.57 M(+2.0%) |
| Sept 2003 | - | -$200.56 M(+1.1%) |
| June 2003 | - | -$198.45 M(+1.6%) |
| Mar 2003 | - | -$195.26 M(+1.8%) |
| Dec 2002 | -$191.90 M(+7.8%) | -$191.90 M(+1.8%) |
| Sept 2002 | - | -$188.43 M(+0.1%) |
| June 2002 | - | -$188.15 M(+2.8%) |
| Mar 2002 | - | -$182.99 M(+2.8%) |
| Dec 2001 | -$178.07 M(+14.6%) | -$178.07 M(+4.0%) |
| Sept 2001 | - | -$171.22 M(+3.8%) |
| June 2001 | - | -$164.99 M(+3.6%) |
| Mar 2001 | - | -$159.32 M(+2.6%) |
| Dec 2000 | -$155.32 M(+16.5%) | -$155.32 M(+9.5%) |
| Sept 2000 | - | -$141.83 M(+2.6%) |
| June 2000 | - | -$138.19 M(+2.0%) |
| Mar 2000 | - | -$135.47 M(+1.6%) |
| Dec 1999 | -$133.35 M(+9.3%) | -$133.35 M(+2.8%) |
| Sept 1999 | - | -$129.70 M(+2.0%) |
| June 1999 | - | -$127.10 M(+1.8%) |
| Mar 1999 | - | -$124.80 M(+2.3%) |
| Dec 1998 | -$122.00 M(+73.8%) | -$122.00 M(+1.9%) |
| Sept 1998 | - | -$119.70 M(+64.0%) |
| June 1998 | - | -$73.00 M(+1.8%) |
| Mar 1998 | - | -$71.70 M(+2.1%) |
| Dec 1997 | -$70.20 M(+22.9%) | -$70.20 M(+2.0%) |
| Sept 1997 | - | -$68.80 M(+13.3%) |
| June 1997 | - | -$60.70 M(+2.7%) |
| Mar 1997 | - | -$59.10 M(+3.5%) |
| Dec 1996 | -$57.10 M(+23.3%) | -$57.10 M(+4.2%) |
| Sept 1996 | - | -$54.80 M(+4.4%) |
| June 1996 | - | -$52.50 M(+8.9%) |
| Mar 1996 | - | -$48.20 M(+4.1%) |
| Dec 1995 | -$46.30 M(+21.5%) | -$46.30 M(+0.2%) |
| Sept 1995 | - | -$46.20 M(+7.2%) |
| June 1995 | - | -$43.10 M(+6.4%) |
| Mar 1995 | - | -$40.50 M(+6.3%) |
| Dec 1994 | -$38.10 M(+43.8%) | -$38.10 M(+13.1%) |
| Sept 1994 | - | -$33.70 M(+9.8%) |
| June 1994 | - | -$30.70 M(+8.1%) |
| Mar 1994 | - | -$28.40 M(+7.2%) |
| Dec 1993 | -$26.50 M(+41.7%) | -$26.50 M(+9.1%) |
| Sept 1993 | - | -$24.30 M(+10.5%) |
| June 1993 | - | -$22.00 M(+7.8%) |
| Mar 1993 | - | -$20.40 M(+17.2%) |
| Dec 1992 | -$18.70 M(+23.8%) | - |
| Oct 1992 | - | -$17.40 M(+6.7%) |
| July 1992 | - | -$16.30 M(+7.9%) |
| Apr 1992 | - | -$15.10 M(+19.8%) |
| Apr 1992 | -$15.10 M(+43.8%) | - |
| Jan 1992 | - | -$12.60 M(-4.5%) |
| Oct 1991 | - | -$13.20 M(+12.8%) |
| July 1991 | - | -$11.70 M(+11.4%) |
| Apr 1991 | -$10.50 M(+50.0%) | -$10.50 M(+10.5%) |
| Jan 1991 | - | -$9.50 M(+9.2%) |
| Oct 1990 | - | -$8.70 M(+8.8%) |
| July 1990 | - | -$8.00 M(+14.3%) |
| Apr 1990 | -$7.00 M(+16.7%) | -$7.00 M(-4.1%) |
| Jan 1990 | - | -$7.30 M(+21.7%) |
| Apr 1989 | -$6.00 M(+22.4%) | -$6.00 M(+22.4%) |
| Apr 1988 | -$4.90 M(+32.4%) | -$4.90 M(+32.4%) |
| Apr 1987 | -$3.70 M(+27.6%) | -$3.70 M(+27.6%) |
| Apr 1986 | -$2.90 M | -$2.90 M |
FAQ
- What is Celldex Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Celldex Therapeutics?
- What is Celldex Therapeutics annual retained earnings year-on-year change?
- What is Celldex Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly retained earnings year-on-year change?
What is Celldex Therapeutics annual retained earnings?
The current annual retained earnings of CLDX is -$1.40 B
What is the all time high annual retained earnings for Celldex Therapeutics?
Celldex Therapeutics all-time high annual retained earnings is -$2.90 M
What is Celldex Therapeutics annual retained earnings year-on-year change?
Over the past year, CLDX annual retained earnings has changed by -$141.43 M (-11.26%)
What is Celldex Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CLDX is -$1.51 B
What is the all time high quarterly retained earnings for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly retained earnings is -$2.90 M
What is Celldex Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CLDX quarterly retained earnings has changed by -$154.08 M (-11.38%)